The Hirshberg Foundation is thrilled to have the distinguished specialists on early diagnosis of pancreatic cancer, Dr. Chari, join us for our 15th Annual Symposium on Pancreatic Cancer on March 2nd, 2019.
Suresh Chari, MD is currently Professor of Medicine and a Consultant in the Division of Gastroenterology and Hepatology at Mayo Clinic College of Medicine in Rochester, MN.
Dr. Chari trained in Internal Medicine and Gastroenterology in India as well as the United States. He has been the Director of Pancreas Clinic at Mayo Clinic Rochester. He has been Councilor and past President of the American Pancreatic Association as well as Councilor and past President of the International Association of Pancreatology. His NIH-funded research has been on new-onset diabetes as an early marker of pancreatic cancer. He was principal investigator of EXPAND trial, the first prospective pilot screening study for sporadic pancreatic cancer in subjects with new-onset diabetes. He is also the principal investigator at Mayo Clinic for the U01 Consortium for Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer in which he is co-leading a prospective study on new-onset diabetes.
Dr. Chari will discuss Clues to Early Diagnosis.
To learn more about Suresh Chari, MD please visit